Growth Metrics

Cellectis (CLLS) Depreciation & Amortization (IS) (2016 - 2022)

Historic Depreciation & Amortization (IS) for Cellectis (CLLS) over the last 8 years, with Q2 2023 value amounting to -$4.4 million.

  • Cellectis' Depreciation & Amortization (IS) rose 1325.37% to -$4.4 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$8.7 million, marking a year-over-year decrease of 7444.31%. This contributed to the annual value of $11.7 million for FY2022, which is 5388.57% up from last year.
  • Latest data reveals that Cellectis reported Depreciation & Amortization (IS) of -$4.4 million as of Q2 2023, which was up 1325.37% from -$4.5 million recorded in Q1 2023.
  • Cellectis' Depreciation & Amortization (IS)'s 5-year high stood at $5.3 million during Q4 2022, with a 5-year trough of -$5.6 million in Q1 2022.
  • In the last 5 years, Cellectis' Depreciation & Amortization (IS) had a median value of -$410676.0 in 2019 and averaged -$495935.2.
  • As far as peak fluctuations go, Cellectis' Depreciation & Amortization (IS) soared by 6688.95% in 2020, and later crashed by 89940.7% in 2022.
  • Cellectis' Depreciation & Amortization (IS) (Quarter) stood at $1.9 million in 2019, then skyrocketed by 66.89% to $3.2 million in 2020, then skyrocketed by 55.27% to $5.0 million in 2021, then grew by 4.5% to $5.3 million in 2022, then tumbled by 184.13% to -$4.4 million in 2023.
  • Its last three reported values are -$4.4 million in Q2 2023, -$4.5 million for Q1 2023, and $5.3 million during Q4 2022.